175Yb-labeled hydroxyapatite: a potential agent for use in radiation synovectomy of small joints

Nuclear Medicine and Biology

Volumn 33, Issue 4, 2006, Pages 585-591

  Chakraborty, Sudipta ^a   Das, Tapas ^a   Banerjee, Sharmila ^a   Subramanian, Suresh ^a   Sarma, Haladhar Dev ^a   Venkatesh, Meera ^a  

^a BHABHA ATOMIC RESEARCH CENTRE   (India)

Author keywords

175Yb; Arthritis; Hydroxyapatite; Radiation synovectomy

Indexed keywords

HYDROXYAPATITE; HYDROXYAPATITE YB 175; UNCLASSIFIED DRUG; YTTERBIUM; RADIOISOTOPE; RADIOPHARMACEUTICAL AGENT;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG STABILITY; DRUG SYNTHESIS; IN VITRO STUDY; ISOTOPE LABELING; JOINT; KNEE ARTHRITIS; MALE; NEUTRON RADIATION; NONHUMAN; PH; RADIATION; RADIOASSAY; RADIOCHEMISTRY; RAT; ROOM TEMPERATURE; SCINTIGRAPHY; SYNOVECTOMY; ANIMAL; ANTIBODY SPECIFICITY; CHEMISTRY; FEASIBILITY STUDY; KNEE OSTEOARTHRITIS; METABOLIC CLEARANCE RATE; METABOLISM; SYNTHESIS; TISSUE DISTRIBUTION; WISTAR RAT;

ANIMALS; DURAPATITE; FEASIBILITY STUDIES; ISOTOPE LABELING; MALE; METABOLIC CLEARANCE RATE; ORGAN SPECIFICITY; OSTEOARTHRITIS, KNEE; RADIOISOTOPES; RADIOPHARMACEUTICALS; RATS; RATS, WISTAR; TISSUE DISTRIBUTION; YTTERBIUM;

EID: 33646557622     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.nucmedbio.2006.02.004     Document Type: Article

References (28)

1. Schneider P., Farahati J., and Reiners C. Radiosynovectomy in rheumatology, orthopedics, and hemophilia. J Nucl Med 46 (2005) 48S-54S
2. Deutsch E., Brodack J.W., and Deutsch K.F. Radiation synovectomy revisited. Eur J Nucl Med 20 (1993) 1113-1127
3. O'Dell J.R. Rheumatoid arthritis: the clinical picture. In: Koopman W.J. (Ed). Arthritis and allied conditions. A textbook of rheumatology. 14th ed. (2001), Lippincott Williams & Wilkins 1153-1186
4. 188Re-tin-colloid as a new therapeutic agent for rheumatoid arthritis. Nucl Med Commun 24 (2003) 689-696
5. Chinol M., Vallabhajosula S., Goldsmith S.J., Klein M.J., Deutsch K.F., Chinen L.K., et al. Chemistry and biological behaviour of samarium-153 and rhenium-186-labeled hydroxyapatite particles: potential radiopharmaceuticals for radiation synovectomy. J Nucl Med 34 (1993) 1536-1542
6. Siegel M.E., Siegal H.J., and Luck J.V. Radiosynovectomy's clinical applications and cost effectiveness: a review. Semin Nucl Med 4 (1997) 364-371
7. Clunie G., Lui D., Cullum I., Edwards J.C.W., and Ell P.J. Samarium-153-particulate hydroxyapatite for radiation synovectomy: biodistribution data for chronic knee synovitis. J Nucl Med 36 (1995) 51-57
8. 166Ho-ferric hydroxide: a first experience. J Nucl Med 43 (2002) 1489-1494
9. Zuckerman J.D., Sledge C.B., Shortkroff S., and Venkateshan P. Treatment of rheumatoid arthritis using radiopharmaceuticals. Nucl Med Biol 14 (1987) 211-218
10. Hosain F., Haddon M.J., Hosain H., Drost J.K., and Spencer R.P. Radiopharmaceuticals for diagnosis and treatment of arthritis. Nucl Med Biol 17 (1990) 151-155
11. 90Y labeled particles for use in radiation synovectomy. Appl Radiat Isot 55 (2001) 471-475
12. Davis M.A., and Chinol M. Radiopharmaceuticals for radiation synovectomy: evaluation of two yttrium-90 particulate agents. J Nucl Med 30 (1989) 1047-1055
13. 165Dy ferric hydroxide macroaggregates for radiation synovectomy. J Nucl Med 19 (1978) 303-308
14. 166Ho labeled hydroxyapatite (HA) particles for radiosynovectomy. Nucl Med Biol 29 (2002) 199-209
15. Noble J., Jones A.G., Davis M.A., Sledge C.B., Kramer R.I., and Livni E. Leakage of radioactive particle systems from a synovial joint studied with a gamma camera: its application to radiation synovectomy. J Bone Joint Surg 65A (1983) 381-389
16. 169 Erbium-citrate synoviorthesis after failure of local corticosteroid injections to treat rheumatoid arthritis-affected finger joints. Clin Exp Rheumatol 22 (2004) 722-726
17. Kampen W.U., Hellweg L., Massoudi-Nickel S., Czech N., Brenner W., and Henze E. Clinical efficacy of radiation synovectomy in digital joint osteoarthritis. Eur J Nucl Med Mol Imaging 32 (2005) 575-580
18. Modder G. Radiosynoviorthesis - involvement of nuclear medicine in rheumatology and orthopaedics (2001), Warlich Druck und Verlagsges, Germany 31-40
19. Siegel H.J., Luck Jr. V.J., and Siegel M.E. Advances in radionuclide therapeutics in orthopaedics. J Am Acad Orthop Surg 12 (2004) 55-64
20. Firestone R. Table of isotopes. 8th ed. In: Shirley V.S. (Ed) (1996), John Wiley and Sons Inc., New York
21. Shortkroff S., Mahmood A., Sledge C.B., and Jones A.G. Studies on Ho-166-labelled hydroxyapatite: a new agent for radiation synovectomy. J Nucl Med 33 (1992) 937 [Abstract]
22. In: Kleinberg J. (Ed). Inorganic synthesis vol. VII (1988), Tata McGraw Hill Book Co. Inc., New York 63-64
23. Liu S., and Edwards D.S. Bifunctional chelators for therapeutic lanthanide radiopharmaceuticals. Bioconj Chem 12 (2001) 7-34
24. Cacheris W.P., Nickle S.K., and Sherry A.D. Thermodynamic study of lanthanide complexes of 1,4,7-triazacyclononane-N,N′,N″-triacetic acid and 1,4,7,10-tetraazacyclododecane-N,N′,N″,N‴-tetraacetic acid. Inorg Chem 26 (1987) 958-960
25. 175Yb labeled polyaminophosphonates as potential agents for bone pain palliation. Appl Radiat Isot 60 (2004) 635-642
26. Manil L., Voisin P., Aubert B., Guerreau D., Verrier P., Lebegue L., et al. Physical and biological dosimetry in patients undergoing radiosynoviorthesis with erbium-169 and rhenium-186. Nucl Med Commun 22 (2001) 405-416
27. Johnson L.S., Yanch J.C., Shortkoff C.L., Barnes A.I., Spitzer A.I., and Sledge C.B. Beta-particle dosimetry in radiation synovectomy. Eur J Nucl Med 22 (1995) 977-988
28. Fischer M., and Mooder G. Radionuclide therapy of inflammatory joint diseases. Nucl Med Commun 23 (2002) 829-831